NOV INC (NOV) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:NOV • US62955J1034
18.35 USD
-0.25 (-1.34%)
At close: Jan 30, 2026
18.29 USD
-0.06 (-0.33%)
After Hours: 1/30/2026, 8:09:22 PM
ChartMill assigns a Buy % Consensus number of 71% to NOV. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 17.55. This target is -4.33% below the current price.
- NOV was analyzed by 25 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about NOV.
- In the previous month the buy percentage consensus was at a similar level.
- NOV was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-07 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-07 | Susquehanna | Maintains | Positive -> Positive |
| 2025-12-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-12-17 | Barclays | Maintains | Underweight -> Underweight |
| 2025-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-12 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-11 | Barclays | Maintains | Underweight -> Underweight |
| 2025-11-05 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-10-30 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-29 | Stifel | Maintains | Buy -> Buy |
| 2025-10-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-30 | Susquehanna | Maintains | Positive -> Positive |
| 2025-07-30 | Stifel | Maintains | Buy -> Buy |
| 2025-07-30 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-07-30 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-07-16 | Stifel | Maintains | Buy -> Buy |
| 2025-07-01 | Susquehanna | Maintains | Positive -> Positive |
| 2025-06-05 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-05-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-01 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-05-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-30 | Barclays | Maintains | Underweight -> Underweight |
| 2025-04-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-15 | Stifel | Maintains | Buy -> Buy |
| 2025-04-14 | Susquehanna | Maintains | Positive -> Positive |
| 2025-04-10 | Goldman Sachs | Maintains | Sell -> Sell |
NOV INC / NOV FAQ
What is the price target for NOV stock?
25 analysts have analysed NOV and the average price target is 17.55 USD. This implies a price decrease of -4.33% is expected in the next year compared to the current price of 18.35.
How do analysts rate NOV INC (NOV)?
The consensus rating for NOV INC (NOV) is 71.2 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NOV INC (NOV)?
The number of analysts covering NOV INC (NOV) is 25.